FIELD: medicine.
SUBSTANCE: made of biodegradable polymers by electrospinning with layer-by-layer introduction of biologically active molecules into the vascular wall: vascular endothelial growth factor (VEGF), fibroblast growth factor (bFGF) and chemoattractant molecule (SDF-1α). The polymer composition is a mixture of polyhydroxybutyrate-valerate and polycaprolactone (PGBV/PCL), taken in the ratio of 1:2. Electrospinning is performed with the participation of a solution containing a polymer composition with VEGF molecules, and then a solution of polymers with an aqueous fraction of biologically active molecules - bFGF and SDF-1α. The invention can be used in cardiovascular surgery for reconstructive operations on vessels.
EFFECT: tissue-engineering graft fabricated by this method corresponds to the layered structure of the vessel wall of a living organism while preserving the vitality and functional activity of biologically active components before the degradation of the polymer matrix.
3 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TECHNOLOGY OF PRODUCING FUNCTIONALLY ACTIVE BIODEGRADABLE SMALL-DIAMETER VASCULAR PROSTHESES WITH DRUG COATING | 2019 |
|
RU2702239C1 |
TISSUE-ENGINEERED SMALL-DIAMETER VASCULAR GRAFT AND METHOD FOR MAKING IT | 2012 |
|
RU2496526C1 |
METHOD OF MANUFACTURE OF BIODEGRADABLE VASCULAR GRAFTS OF SMALL DIAMETER WITH MODIFIED SURFACE | 2018 |
|
RU2675269C1 |
METHOD FOR MAKING BIORESORBED SMALL-DIAMETER HYBRID VASCULAR GRAFT | 2012 |
|
RU2504406C1 |
FUNCTIONALLY ACTIVE BIODEGRADABLE VASCULAR PATCH FOR ARTERIAL RECONSTRUCTION | 2019 |
|
RU2707964C1 |
CASTING MOLD FOR CREATING A TISSUE-ENGINEERED VASCULAR PROSTHESIS | 2022 |
|
RU2780293C1 |
METHOD FOR IN VITRO PRODUCTION OF A PERSONALIZED CELL-POPULATED VASCULAR PROSTHESIS | 2021 |
|
RU2764051C1 |
METHOD FOR CREATING BIOENGINEERED VASCULAR GRAFTS OF LARGE AND MEDIUM DIAMETERS | 2022 |
|
RU2794913C1 |
METHOD OF MODIFYING SURFACE OF BIODEGRADABLE POLYMER MATERIALS | 2018 |
|
RU2699045C1 |
METHOD FOR PRODUCING A MICROFIBER MATERIAL RELEASING MEDICAMENT | 2017 |
|
RU2669344C1 |
Authors
Dates
2018-01-24—Published
2016-06-14—Filed